Peroxisome proliferator-activated gamma (PPARγ) is a ligand-activated member of the nuclear hormone receptor superfamily and controls adipocyte differentiation and function, and thus becomes a classic target to treat obesity-related disorders [1, 8]. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.